(Q30587206)

25 June 2017

title

Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data (English)

1 reference

25 June 2017

0 references

0 references

1 reference

3

0 references

author name string

Hans Van Brabandt

series ordinal

1

1 reference

25 June 2017

Mattias Neyt

series ordinal

2

1 reference

25 June 2017

Carl Devos

series ordinal

3

1 reference

25 June 2017

publication date

6 February 2013

1 reference

25 June 2017

1 reference

25 June 2017

volume

15

1 reference

25 June 2017

issue

5

1 reference

25 June 2017

page(s)

663-668

1 reference

Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation.

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Circumferential pulmonary-vein ablation for chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Sustainability of medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design:

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT004

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUT004

1 reference

25 June 2017

1 reference